Hulman, Adam
Simmons, Rebecca K.
Brunner, Eric J.
Witte, Daniel R.
Færch, Kristine
Vistisen, Dorte
Ikehara, Satoyo
Kivimaki, Mika
Tabák, Adam G.
Funding for this research was provided by:
US National Institutes of Health (R01HL36310)
British Heart Foundation (RG/13/2/30098)
Danish Diabetes Academy
UK Medical Research Council (MR/K013351/1)
Article History
Received: 25 November 2016
Accepted: 15 March 2017
First Online: 13 April 2017
Data availability
: Whitehall II data are available to bona fide researchers for research purposes. Please refer to the Whitehall II data sharing policy at ExternalRef removed.
: AH, RKS and DRW are supported by the Danish Diabetes Academy. The Danish Diabetes Academy is funded by the Novo Nordisk Foundation. RKS is further supported by the Aarhus Institute of Advanced Studies. KF is supported by the Novo Nordisk Foundation. EJB is supported by the British Heart Foundation (RG/13/2/30098).The UK Medical Research Council (MR/K013351/1; G0902037), the British Heart Foundation (RG/13/2/30098) and the US National Institutes of Health (R01HL36310, R01AG013196) have supported collection of data in the Whitehall II study.
: The authors declare that there is no duality of interest associated with this manuscript.
: AH was responsible for the data analysis. RKS and AH wrote the first draft of the manuscript with major contributions from AGT. EJB had the original idea for the study. AGT, MK and EJB contributed to the conception and design of the study and the data acquisition. All authors contributed to the interpretation of the data and critical revision of the manuscript, and approved the final version. AH is the guarantor of this work and, as such, had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.